This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of compounded chemotherapy medications. The contract is valued at $340,949.82 and has an ultimate completion date of September 30, 2024.
The original solicitation was for the VA Long Beach Healthcare System to acquire approximately 30 hazardous chemotherapy drugs and supportive medications to be delivered weekly over a 12-month period. The solicitation was unrestricted, with no set-aside designation. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group, was selected as the prime contractor based on its expertise in aseptic compounding and hazardous drug preparation for VA oncology and infusion treatment programs nationwide. This contract award is part of Avella's broader portfolio of Indefinite Delivery Vehicles with the VA for the provision of specialized pharmacy services, including chemotherapy compounding and hazardous pharmaceutical compounds, across the VA healthcare system.